Adapting and Testing a Novel Digital Health Tool (PREVENT) to Improve Health Behavior Counseling and Cardiovascular Health in Rural Primary Care Clinics
Launched by WASHINGTON UNIVERSITY SCHOOL OF MEDICINE · Sep 28, 2023
Trial Information
Current as of August 19, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, called PREVENT, is studying a new digital health tool designed to help improve the health of patients living in rural areas, particularly those who are low-income and struggling with obesity and heart disease. The goal is to provide better health behavior counseling, which means giving patients advice and support on how to eat healthier and be more active. The tool allows healthcare providers to see important health information about patients during their visits, making it easier to create personalized plans for improving their health.
To be eligible for this trial, participants must be between 18 and 64 years old, have a household income below 200% of the poverty level, have a body mass index (BMI) of 30 or higher (which indicates obesity), and be receiving care from Missouri Highlands. Participants will work closely with healthcare teams to use the PREVENT tool, which aims to make healthcare more accessible and effective for rural residents. While the trial is not yet recruiting, it is an exciting opportunity to help improve cardiovascular health in underserved communities.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Aged 18-64 years at baseline
- • low-income (household income \<200% poverty)
- • a BMI ≥ 30
- • Receiving care from the Missouri Highlands.
- • Ability to understand and willingness to sign an IRB approved written informed consent document (or that of legally authorized representative, if applicable).
About Washington University School Of Medicine
Washington University School of Medicine is a leading academic medical institution renowned for its commitment to advancing healthcare through innovative research, education, and patient care. With a strong emphasis on translating scientific discoveries into practical applications, the institution conducts a diverse array of clinical trials aimed at improving treatment outcomes and enhancing the understanding of various medical conditions. Its collaborative environment fosters partnerships between researchers, clinicians, and community stakeholders, ensuring that the trials not only contribute to scientific knowledge but also address the pressing health needs of diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
St. Louis, Missouri, United States
Saint Louis, Missouri, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported